We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Psychedelics and the Neurobiology of Fast-acting Antidepressants

Published: Mar 22, 2022   
 

Depression is debilitating, yet treatment options are limited. Psychedelics have emerged as potentially impactful drugs with promise of long-lasting beneficial actions. As a result, there are growing efforts to optimize their use in the clinic and to develop next-generation psychedelics with improved pharmacological profiles. One major challenge, however, is that we still do not have a full understanding of how psychedelics work in the brain.

In this seminar, I will describe my lab’s work on fast-acting antidepressants. I will talk about experiments in animal models that have identified cell types and neural plasticity processes involved in ketamine and psilocybin’s actions. I will discuss how the biological insights may lead to novel circuit-level biomarkers, which are crucially needed to accelerate the search for new psychiatric drugs.


  More Information
 

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement